Effect of gender on the prognostic value of dobutamine stress myocardial contrast echocardiography.

[1]  Jin‐Ho Choi,et al.  Independent and incremental prognostic value of exercise stress echocardiography in low cardiovascular risk female patients with chest pain , 2017, Echocardiography.

[2]  P. Pellikka,et al.  The role of stress echocardiography in the evaluation of coronary artery disease and myocardial ischemia in women , 2016, Journal of Nuclear Cardiology.

[3]  S. Foussas.  Differences in men and women in acute coronary syndromes. , 2016, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[4]  M. Walsh,et al.  Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. , 2016, JACC. Cardiovascular imaging.

[5]  I. Mrdović,et al.  Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2016, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[6]  R. Senior,et al.  The incremental prognostic value of the incorporation of myocardial perfusion assessment into clinical testing with stress echocardiography study. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  M. Walsh,et al.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography. , 2015, Journal of the American College of Cardiology.

[8]  Puja K. Mehta,et al.  Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy , 2015, Nature Reviews Cardiology.

[9]  Lynette M. Smith,et al.  Differences in patient outcomes after conventional versus real time perfusion stress echocardiography in men versus women: a prospective randomised trial , 2015, Heart.

[10]  D. Berman,et al.  Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease: A Consensus Statement From the American Heart Association , 2014, Circulation.

[11]  C. Stefanadis,et al.  Dobutamine stress contrast echocardiography in patients with coronary artery disease: the prognostic impact of age. , 2014, International journal of cardiology.

[12]  P. Pellikka,et al.  A multicenter, prospective study to evaluate the use of contrast stress echocardiography in early menopausal women at risk for coronary artery disease: trial design and baseline findings. , 2013, Journal of women's health.

[13]  C. Rochitte,et al.  Incremental Value of Perfusion over Wall‐Motion Abnormalities with the Use of Dobutamine–Atropine Stress Myocardial Contrast Echocardiography and Magnetic Resonance Imaging for Detecting Coronary Artery Disease , 2013, Echocardiography.

[14]  V. Lorenzoni,et al.  Prognostic Value of High-Dose Dipyridamole Stress Myocardial Contrast Perfusion Echocardiography , 2012, Circulation.

[15]  M. Vannan,et al.  Prognostic value of real time dobutamine stress myocardial contrast echocardiography in patients with chest pain syndrome , 2011, The International Journal of Cardiovascular Imaging.

[16]  J. Kasprzak,et al.  Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[17]  G. Heller,et al.  Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[18]  J. Kasprzak,et al.  Influence of gender on diagnostic accuracy of rapid atrial and ventricular pacing stress echocardiography for the detection of coronary artery disease: a multicenter study (Pol-RAPSE final results). , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  C. Stefanadis,et al.  Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies , 2008, Heart.

[20]  M. Takeuchi,et al.  Role of Contrast‐Enhanced Dobutamine Stress Echocardiography in Predicting Outcome in Patients with Known or Suspected Coronary Artery Disease , 2006, Echocardiography.

[21]  M. Takeuchi,et al.  Quantitative assessment of left ventricular function during contrast-enhanced dobutamine stress echocardiography predicts future cardiac events in diabetic patients. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[22]  A. Lerman,et al.  Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter? , 2006, Journal of the American College of Cardiology.

[23]  James R. Anderson,et al.  Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion Echocardiography , 2005, Circulation.

[24]  James R. Anderson,et al.  Diagnostic Accuracy and Prognostic Value of Dobutamine Stress Myocardial Contrast Echocardiography in Patients with Suspected Acute Coronary Syndromes , 2005, Echocardiography.

[25]  L. Shaw,et al.  Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. , 2005, European heart journal.

[26]  D. Berman,et al.  Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. , 2003, Journal of the American College of Cardiology.

[27]  Adelaide M. Arruda-Olson,et al.  Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? , 2002, Journal of the American College of Cardiology.

[28]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[29]  V. Roger,et al.  Prognostic value of exercise echocardiography in 2,632 patients > or = 65 years of age. , 2001, Journal of the American College of Cardiology.

[30]  M. Segal,et al.  Meta-analysis of exercise testing to detect coronary artery disease in women. , 1999, The American journal of cardiology.

[31]  J. Collins,et al.  The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  V. Lorenzoni,et al.  Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography. , 2013, JACC. Cardiovascular imaging.

[33]  I. Olivotto,et al.  The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. , 2001, European heart journal.